Academic literature on the topic 'Lili Morani'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Lili Morani.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Lili Morani"

1

Furie, R., E. F. Morand, A. Askanase, et al. "SAT0174 FLARE ASSESSMENTS IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH ANIFROLUMAB IN 2 PHASE 3 TRIALS." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 1028.1–1029. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3681.

Full text
Abstract:
Background:Anifrolumab treatment resulted in improved British Isles Lupus Assessment Group (BILAG)–based Composite Lupus Assessment (BICLA) response rates in patients with systemic lupus erythematosus (SLE) in the phase 3 TULIP-2 and TULIP-1 trials.1,2In addition, annualized flare rates were lower among the groups treated with anifrolumab compared with placebo.1,2Objectives:TULIP-2 and TULIP-1 data were analyzed to assess the effects of anifrolumab on the number of SLE flares and time to first flare during 52 weeks of treatment.Methods:The randomized, double-blind, placebo-controlled TULIP-2 a
APA, Harvard, Vancouver, ISO, and other styles
2

Morand, E. F., R. Furie, I. N. Bruce, et al. "OP0003 EARLY AND SUSTAINED RESPONSES WITH ANIFROLUMAB TREATMENT IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN 2 PHASE 3 TRIALS." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 2.1–3. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3538.

Full text
Abstract:
Background:In the phase 3 TULIP-2 and TULIP-1 trials in SLE, treatment with the type I interferon receptor antibody anifrolumab resulted in higher percentages of patients with BICLA responses vs placebo at Week 52, with differences of 16.3% (primary endpoint; P=0.001, 95% CI 6.3–26.3) and 16.4% (secondary endpoint; 95% CI 6.7–26.2), respectively.1,2Objectives:To better understand the time course of BICLA responses to anifrolumab, we examined responses over time compared with placebo in TULIP-2 and TULIP-1, including those that were sustained from attainment through Week 52.Methods:The TULIP-2
APA, Harvard, Vancouver, ISO, and other styles
3

Franceschi, Franco. "Luca Molà, La comunità dei Lucchesi a Venezia. Immigrazione e industria della seta nel tardo Medioevo, Venise, Istituto veneto di Scienze, Lettere ed Arti, « Memorie, Classe di Scienze morali, Lettere ed Arti, LIII », 1994, 354 p." Annales. Histoire, Sciences Sociales 51, no. 5 (1996): 1137–39. http://dx.doi.org/10.1017/s039526490005188x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Morand, E. F., R. Furie, Y. Tanaka, et al. "OP0049 EFFICACY OF ANIFROLUMAB IN ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: PATIENT SUBGROUP ANALYSIS OF BICLA RESPONSE IN 2 PHASE 3 TRIALS." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 32. http://dx.doi.org/10.1136/annrheumdis-2020-eular.3557.

Full text
Abstract:
Background:Treatment of patients with systemic lupus erythematosus (SLE) with the type I interferon (IFN) receptor inhibitor anifrolumab resulted in higher British Isles Lupus Assessment Group (BILAG)–based Composite Lupus Assessment (BICLA) response rates vs placebo at Week 52 in the phase 3 randomized trials, TULIP-2 (primary endpoint; 16.3% difference)1and TULIP-1 (secondary endpoint; 16.4% difference).2BICLA is a validated composite global disease measure that registers both partial and complete improvement within organ systems.Objectives:TULIP-2 and TULIP-1 data were analyzed to evaluate
APA, Harvard, Vancouver, ISO, and other styles
5

Cheang, Maggie Chon U., Monisha Dewan, Lucy Kilburn, et al. "Abstract P2-03-07: Multi-parametric algorithm integrating on-treatment Ki67 value and standard clinicopathological variables to predict risk of recurrences for women > 70 years old with early ER+HER2- tumours in POETIC trial." Cancer Research 83, no. 5_Supplement (2023): P2–03–07—P2–03–07. http://dx.doi.org/10.1158/1538-7445.sabcs22-p2-03-07.

Full text
Abstract:
Abstract Background: Prognosis in older patients with breast cancer (BC) is worse compared to younger patients. No robust and specific tool to predict the risk of recurrence (TTR) for women aged 70 and over is likely due to the lack of representation of this group in the data from clinical trials. In the POETIC trial, of estrogen receptor-positive (ER+) and mainly human epidermal growth factor receptor 2 negative (HER2-) BC (88%), peri-operative aromatase inhibitor (POAI) did not improve treatment outcome, but patients with low baseline Ki67 value (Ki67B) or low POAI-induced Ki67 value (Ki67_2
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Lili Morani"

1

Nascimento, Maria Silvia do [UNESP]. "Olha a palhaça no meio da praça: Lily Curcio, Lilian Moraes, questões de gênero, comicidade e muito mais!" Universidade Estadual Paulista (UNESP), 2017. http://hdl.handle.net/11449/151957.

Full text
Abstract:
Submitted by Maria Silvia do Nascimento null (mariasilvinha@uol.com.br) on 2017-10-18T13:52:39Z No. of bitstreams: 1 NASCIMENTO, Maria Silvia do - Olha a palhaça - dissertação_vf.pdf: 13285586 bytes, checksum: ddecab6e1d4c8786d9590bb6068742ff (MD5)<br>Approved for entry into archive by Luiz Galeffi (luizgaleffi@gmail.com) on 2017-10-23T18:56:03Z (GMT) No. of bitstreams: 1 nascimento_ms_me_ia.pdf: 13285586 bytes, checksum: ddecab6e1d4c8786d9590bb6068742ff (MD5)<br>Made available in DSpace on 2017-10-23T18:56:03Z (GMT). No. of bitstreams: 1 nascimento_ms_me_ia.pdf: 13285586 bytes, checksum:
APA, Harvard, Vancouver, ISO, and other styles
2

Nascimento, Maria Silvia do. "Olha a palhaça no meio da praça : Lily Curcio, Lilian Moraes, questões de gênero, comicidade e muito mais! /." São Paulo, 2017. http://hdl.handle.net/11449/151957.

Full text
Abstract:
Orientador: Mario Fernando Bolognesi<br>Banca: Cintia Lima Crescêncio<br>Banca: Lucia Regina Vieira Romano<br>Resumo: Esta pesquisa aborda as questões de gênero relacionadas à palhaçaria valendo-se do repertório e experiências das artistas Lily Curcio e Lilian Moraes. Para tal aproximação, sua metodologia inclui a apreciação crítica de apresentações de diversas palhaças, entrevistas com artistas e análise de suas biografias, vivência em processos de formação em palhaçaria e as experiências da própria autora enquanto pesquisadora e palhaça. São abordados diversos referenciais teóricos acerca da
APA, Harvard, Vancouver, ISO, and other styles
3

STARNINI, MARTINA. ""La rivoluzione morale, lo spirito del secolo". Storia di Carlo Livi, freniatra dell'Ottocento (1823-1877)." Doctoral thesis, 2017. http://hdl.handle.net/2158/1084956.

Full text
Abstract:
L'elaborato si basa sulla biografia storica dello psichiatra pratese Carlo Livi (1823-1877), una delle figure chiave della psichiatra italiana dell’Ottocento. La tesi si sofferma sia sulla sua opera di carattere medico-psichiatrico e medico-forense, sia sulle tappe fondamentali della sua vita di uomo, di medico e di intellettuale vissuto durante gli anni centrali del Risorgimento italiano.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Lili Morani"

1

Sosnovskiĭ, Aleksandr. Liki li͡u︡bvi: Ocherki istorii polovoĭ morali. Izd-vo "Znanie", 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Storie di Arsoli. Arbor Sapientiae, 2023.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Lili Morani"

1

Dellming, Elisabet. "Knowing What Matters: The Epistemological and Ethical Challenge of Marilynne Robinson’s Lila." In Fictional Worlds and the Moral Imagination. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-55049-3_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

"6. Robert Henryson, Morall Fabillis." In The Lily and the Thistle. University of Toronto Press, 2013. http://dx.doi.org/10.3138/9781442666245-008.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Lili Morani"

1

Dmitriev, Sergey, Lev Prozorov, Aleksey Tkachenko, Andrey Guskov, and Svetlana Korneva. "Design and Siting for Large Diameter Well Type Repositories." In ASME 2003 9th International Conference on Radioactive Waste Management and Environmental Remediation. ASMEDC, 2003. http://dx.doi.org/10.1115/icem2003-5013.

Full text
Abstract:
RADON enterprises are historically responsible in Russia for institutional waste of low and intermediate activity level. MosNPO RADON is a leading organization for 16 enterprises of RADON system, established in the early 60-s, only 14 from which are now in operation and have about 10% of their repositories available for upcoming waste. Construction of new repositories and selection of new perspective sites is very actual problem for RAW management in Russia now. Traditionally near surface repositories are considered to be acceptable for storage or even disposal of low and intermediate level wa
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!